Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen
Sandeep S Saluja,1 Douglas J Hanlon,1 Fiona A Sharp,2 Enping Hong,2 David Khalil,1 Eve Robinson,1 Robert Tigelaar,1 Tarek M Fahmy,2,3 Richard L Edelson1 1Department of Dermatology, Yale University School of Medicine, 2Department of Biomedical Engineering, Yale University, 3Department of I...
Guardado en:
Autores principales: | Saluja SS, Hanlon DJ, Sharp FA, Hong E, Khalil D, Robinson E, Tigelaar R, Fahmy TM, Edelson RL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28df43de85bd483294bbcc482ad39c70 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles
por: Jahan ST, et al.
Publicado: (2015) -
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
por: Jahan ST, et al.
Publicado: (2018) -
Acta Nº205
por: Banco Central de Chile
Publicado: (2019) -
CHRONO and DEC1/DEC2 compensate for lack of CRY1/CRY2 in expression of coherent circadian rhythm but not in generation of circadian oscillation in the neonatal mouse SCN
por: Daisuke Ono, et al.
Publicado: (2021) -
Evaluation of the Antitumour and Antiproliferative Effect of Xanthohumol-Loaded PLGA Nanoparticles on Melanoma
por: Magda Fonseca, et al.
Publicado: (2021)